Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

China flag China · Delayed Price · Currency is CNY
116.50
-0.51 (-0.44%)
Apr 17, 2026, 3:09 PM CST
Market Cap18.55B +219.5%
Revenue (ttm)430.98M -8.2%
Net Income-197.25M
EPS-1.24
Shares Out159.27M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,460,173
Average Volume11,115,006
Open112.22
Previous Close117.01
Day's Range112.22 - 117.79
52-Week Range28.03 - 188.93
Beta1.24
RSI53.16
Earnings DateApr 29, 2026

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 760
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300436
Full Company Profile

Financial Performance

In 2024, SHE:300436's revenue was 441.46 million, an increase of 4.43% compared to the previous year's 422.71 million. Losses were -156.30 million, -55.16% less than in 2023.

Financial Statements